Sign in

CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
operating
EIN
621765329
Phone
615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
  1. 4 Open-market buy Chairman and CEO bought 1,680 shares at an average $6.23 ($10,463)
  2. 4 Open-market buy Director bought 1,680 shares at an average $6.23 ($10,463)
  3. 4 Open-market sale Director sold 7,471 shares at an average $5.77 ($43,117)
  4. 4 Open-market buy Director bought 1,554 shares at an average $6.23 ($9,677)
  5. 4 Open-market sale Director sold 14,376 shares at an average $6.28 ($90,286)
  6. 4 Open-market sale Director sold 13,264 shares at an average $6.31 ($83,741)
  7. 4 Open-market sale Director sold 8,876 shares at an average $6.22 ($55,187)
  8. 4 Open-market buy Director bought 1,971 shares at an average $6.32 ($12,447)
  9. 4 Open-market sale Director sold 21,640 shares at an average $6.28 ($135,951)
  10. 4 Open-market buy Chairman and CEO bought 1,682 shares at an average $6.36 ($10,690)
  11. 4 Open-market buy Director bought 1,682 shares at an average $6.36 ($10,690)
  12. 4 Shares withheld for taxes SVP and Chief Development Off. gave up 1,850 shares (to pay taxes)
  13. 4 Open-market buy Director bought 6,695 shares at an average $6.27 ($42,007)
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. 4 Open-market buy Director bought 3,846 shares at an average $5.87 ($22,578)
  17. 4 Open-market buy Director bought 3,708 shares at an average $6.15 ($22,790)
  18. 8-K Event Shareholder vote results
  19. 4 Open-market buy Director bought 1,526 shares at an average $6.13 ($9,351)
  20. 4 Open-market buy Chairman and CEO bought 1,526 shares at an average $6.13 ($9,351)

Page 25 of 52 · 1,039 filings